go back

Prostate Cancer Antibody Response Score

Rhode Island rates for HCPCS 0021U

Assesses the likelihood of prostate cancer by measuring the immune system's antibody response to eight tumor-associated proteins, including ARF6, NKX3-1, BMI1, CEP164, Ropporin, desmocollin, AURKAIP-1 and CSNK2A2. The eight results are combined into a single risk score, and no genetic material is examined.

Facilitymedian $3,467 · 10th–90th $1,622$3,4670%50%10th$3,467Professionalmedian $537 · 10th–90th $501$5620%50%10th90th$537$0.0$0.2$2.0$20.0$200.0$2.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$2,187.76
Median
$3,467.37
Typical High
$3,467.37
Aetna
Setting
Professional
Modifier
Global
Typical Low
$501.19
Median
$537.03
Typical High
$562.34
BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$1,621.81
Typical High
$1,819.70
Cigna
Setting
Facility
Modifier
Global
Typical Low
$2,344.23
Median
$2,344.23
Typical High
$2,344.23
Cigna
Setting
Professional
Modifier
Global
Typical Low
$870.96
Median
$870.96
Typical High
$1,096.48
United
Setting
Facility
Modifier
Global
Typical Low
$912.01
Median
$912.01
Typical High
$912.01
United
Setting
Professional
Modifier
Global
Typical Low
$380.19
Median
$457.09
Typical High
$1,096.48